Incidence of Hospital-Acquired Pneumonia, Bacteraemia and Urinary Tract Infections in Patients with Haematological Malignancies, 2004-2010: A Surveillance-Based Study

被引:34
作者
Huoi, Catherine [1 ]
Vanhems, Philippe [1 ,2 ]
Nicolle, Marie-Christine [1 ]
Michallet, Mauricette [3 ]
Benet, Thomas [1 ,2 ]
机构
[1] Hosp Civils Lyon, Infect Control & Epidemiol Unit, Edouard Herriot Hosp, Lyon, France
[2] Univ Lyon 1, Epidemiol & Publ Hlth Grp, CNRS, UMR 5558, F-69365 Lyon, France
[3] Hosp Civils Lyon, Dept Haematol, Edouard Herriot Hosp, Lyon, France
来源
PLOS ONE | 2013年 / 8卷 / 03期
关键词
BLOOD-STREAM INFECTIONS; BONE-MARROW-TRANSPLANTATION; NOSOCOMIAL INFECTIONS; INVASIVE ASPERGILLOSIS; IMMUNOCOMPROMISED PATIENTS; NEUTROPENIC PATIENTS; UNKNOWN ORIGIN; ADULT PATIENTS; EPIDEMIOLOGY; MORTALITY;
D O I
10.1371/journal.pone.0058121
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: This study charted incidence trends of hospital-acquired (HA) pneumonia, bacteraemia and urinary tract infections (UTI) in a haematology department. Methods: Prospective surveillance of hospital-acquired infections (HAI) was undertaken in a 42-bed haematology department of a university hospital. All patients hospitalized >= 48 hours between 1 st January 2004 and 31 st December 2010 were included. Definitions of HAI were based on a standardized protocol. The incidence was the number of events per 1000 patient-days at risk; only the first HAI was counted. Multivariate Poisson regression was fitted to assess temporal trends. Results: Among 3 355 patients (58 063 patient-days at risk) included, 1 055 (31%) had HAI. The incidence of HA pneumonia, HA bacteraemia and HA UTI was respectively 3.3, 12.0 and 2.9 per 1000 patient-days at risk. HA bacteraemia incidence increased by 11% (95% confidence interval: +6%, +15%, P<0.001) per year, independently of neutropenia, central venous catheterization (CVC) and haematological disease. The incidences of HA pneumonia and HA UTI were stable. The most frequently isolated pathogens were Aspergillus spp. (59.2%) for pneumonia, coagulase-negative Staphylococcus (44.2%) for bacteraemia and enterobacteria (60%) for UTI. Conclusion: The incidence of bacteraemia increased, indicating that factors other than CVC exposure, including chemotherapy with its impact on the immune system, could explain this trend. Further analytic studies are needed to explore the factors that could explain this trend.
引用
收藏
页数:8
相关论文
共 38 条
[1]   Nosocomial infections and fever of unknown origin in pediatric hematology/oncology unit: a retrospective annual study [J].
Al-Tonbary, Youssef A. ;
Soliman, Othman E. ;
Sarhan, Mohammed M. ;
Hegazi, Moustafa A. ;
El-Ashry, Rasha A. ;
El-Sharkawy, Ashraf A. ;
Salama, Osama S. ;
Yahya, Raida .
WORLD JOURNAL OF PEDIATRICS, 2011, 7 (01) :60-64
[2]   Infections in Pediatric Patients With Hematologic Malignancies [J].
Bailey, L. Charles ;
Reilly, Anne F. ;
Rheingold, Susan R. .
SEMINARS IN HEMATOLOGY, 2009, 46 (03) :313-324
[3]   Correlation of nosocomial bloodstream infection incidences: an ecological study [J].
Benet, T. ;
Vanhems, P. .
JOURNAL OF HOSPITAL INFECTION, 2009, 73 (03) :217-224
[4]  
Benet T., 2007, Clin Infect Dis, V45, P682
[5]  
CARLISLE PS, 1993, INFECT CONT HOSP EP, V14, P320, DOI 10.1086/646750
[6]  
Comite technique des infections nosocomiales, 1999, 100 REC SURV PREV IN
[7]   Epidemiology of invasive aspergillosis in France:: a six-year multicentric survey in the Greater Paris area [J].
Cornet, M ;
Fleury, L ;
Maslo, C ;
Bernard, JF ;
Brücker, G .
JOURNAL OF HOSPITAL INFECTION, 2002, 51 (04) :288-296
[8]   Chemotherapy-induced neutropenia - Risks, consequences, and new directions for its management [J].
Crawford, J ;
Dale, DC ;
Lyman, GH .
CANCER, 2004, 100 (02) :228-237
[9]   Prevention of febrile neutropenia: use of prophylactic antibiotics [J].
Cullen, M. ;
Baijal, S. .
BRITISH JOURNAL OF CANCER, 2009, 101 :S11-S14
[10]   Estimating the impact of healthcare-associated infections on length of stay and costs [J].
De Angelis, G. ;
Murthy, A. ;
Beyersmann, J. ;
Harbarth, S. .
CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (12) :1729-1735